Business
Eli Lilly Expands Weight-Loss Pill Market
Eli Lilly has secured approval for its weight-loss pill Foundayo in the U.K., expanding its market beyond the United States and competing with Novo Nordisk's Wegovy.
Coverage timeline — 1 article
CNBC
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
2026-08-11 09:27 UTC